Investors in AT1 instruments are clear beneficiaries of capital injections and other forms of forbearance, but senior creditors typically would expect any future losses to be cushioned by AT1 investors first taking losses. These policies also create moral hazard by weakening the pressure AT1 instruments should put on banks to recapitalise by raising equity on a more timely and pro-active basis.
Yield spreads between Indian AT1 instruments and gone-concern Tier 2 debt have gradually tightened over the previous few years. The narrowing has been largely driven by market expectations of forbearance as well as strong AT1 demand from mutual funds, which received a surge in liquidity after demonetisation brought cash back into the formal financial sector. The capital injection of INR19 billion (USD300 million) into IDBI on 9 August - ahead of its 1Q18 (April-June) earnings announcement - underscores that the authorities have little appetite to force a coupon skip by a large state-owned bank.
Other state banks have previously received capital injections from government to stave-off skipped coupon payments after coming close to breaching minimum capital adequacy requirements. There have also been several regulatory adjustments in the previous few years that appear to have been timed to avoid potential damage to sentiment in the AT1 market. Most recently, the Reserve Bank of India decided earlier this year to allow banks to use their statutory reserves to pay coupons on AT1 instruments after losses left some banks lacking distributable reserves.
These policies are in response to persistent banking sector losses and weak internal capital generation that will continue to put some banks in danger of breaching minimum capital adequacy ratios, which are set to rise further with the implementation of the Basel III framework over the next two years. IDBI itself reported substantial losses in the financial year ending March 2017 (FY17) and in its 1Q18 results. We had already downgraded the bank's Viability Rating to 'ccc' from 'bb-' to reflect a sharp deterioration in its financial profile that had weakened core capitalisation close to minimum requirements.
Market pricing appears to assume that the government is likely to continue to ensure state banks do not miss coupon payments. There is some pricing distinction between the larger and smaller state banks, but the small premiums on their AT1 instruments suggest pricing is now largely based on assumptions of state support being provided ahead of banks triggering non-performance clauses. Fitch continues to believe that private banks will be allowed to skip coupon payments, but most are in relatively healthy positions.
The increase in AT1 issuance so far this year suggests forbearance is paying off in terms of addressing capital shortfalls. AT1 instruments worth around INR183 billion have been issued by eight banks in April-August, compared with INR48 billion by four banks over the same period in 2016. However, banks are likely to need substantially more than that by FYE19 to meet rising Basel III minimum capital requirements and the government is likely to end up providing much more than the USD10.4 billion already earmarked.
Powered by Capital Market - Live News